← Back to headlines
CVRx stock rebounds following Humana's Medicare policy for Barostim
CVRx shares have seen a rebound after Humana issued a new Medicare policy covering the company's Barostim device.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
